EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Forecasting Disease Burden with a Dynamic Transmission Model of Human Papillomavirus and Recurrent Respiratory Papillomatosis in the United States

Cody Palmer iD, Edith Morais, Joseph Tota

Viruses · 11.08.2024 · 16 (8) · 1283

DOI: 10.3390/v16081283 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, online erschienen am 11.08.2024. Verfasst von Cody Palmer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biostatistics and Research Decision Sciences (BARDS), Merck & Co., Inc., Rahway, NJ 07065, USA. Hauptthemen laut MEDLINE: Papillomavirus Infections, Respiratory Tract Infections, Papillomavirus Vaccines, Forecasting. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Juvenile- and adult-onset recurrent respiratory papillomatosis (JORRP and AORRP) are rare but serious conditions that are caused by oral human papillomavirus (HPV) infections. The proliferation of wart-like growths throughout the respiratory tract can result in medical problems, including death. The current treatment scheme is surgery, though prevention of HPV infection through vaccination is available. A previously developed model for JORRP and AORRP was adapted to the United States using data on disease burden and HPV infection. The model was validated against post-vaccination reductions in disease and used to forecast the future burden of JORRP and AORRP, estimating the impact that HPV vaccination will have on these diseases. Between 2007 (the beginning of HPV vaccination in the US) and 2021, this model estimates that approximately 1393 lives, 22,867 Quality-Adjusted-Life-Years, and over USD 672 million in treatment costs have been saved by HPV vaccination. There is also a substantial reduction in JORRP and AORRP burden, with a 95% reduction in incidence by 2040. Moreover, between 2040 and 2121, the model predicts 3–11 total cases of HPV6/11-related JORRP in the US, and 36–267 total cases of HPV6/11-related AORRP. HPV vaccination in the United States has driven, and will continue to drive, substantial reductions in the public health and economic burden of HPV6/11-related JORRP and AORRP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsRespiratory Tract InfectionsPapillomavirus VaccinesForecastingHumansUnited StatesCost of IllnessFemalePapillomaviridaeVaccinationIncidenceMaleAdultAdolescentYoung AdultChildHuman Papillomavirus Viruses

Stichwörter der Autor:innen

human papillomavirusrecurrent respiratory papillomatosisvaccinationvertical transmission

Substanzen

Papillomavirus Vaccines

Autor:innen und Institutionen

  • Biostatistics and Research Decision Sciences (BARDS), Merck & Co., Inc., Rahway, NJ 07065, USA.
  • MSD, 69007 Lyon, France.

ORCID-Profile: Cody Palmer

Zitieren

APA

Palmer, C., Morais, E., & Tota, J. (2024). Forecasting Disease Burden with a Dynamic Transmission Model of Human Papillomavirus and Recurrent Respiratory Papillomatosis in the United States. Viruses, 16(8), 1283. https://doi.org/10.3390/v16081283

Vancouver

Palmer C, Morais E, Tota J. Forecasting Disease Burden with a Dynamic Transmission Model of Human Papillomavirus and Recurrent Respiratory Papillomatosis in the United States. Viruses. 2024;16(8):1283. doi:10.3390/v16081283

BibTeX
@article{Palmer2024,
  author = {Palmer, Cody and Morais, Edith and Tota, Joseph},
  title = {Forecasting Disease Burden with a Dynamic Transmission Model of Human Papillomavirus and Recurrent Respiratory Papillomatosis in the United States},
  journal = {Viruses},
  year = {2024},
  volume = {16},
  number = {8},
  pages = {1283},
  doi = {10.3390/v16081283}
}
Kostenlos starten →